EVLO — Evelo Biosciences Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Evelo Biosciences Says Co And Abdul Latif Jameel Health Entered Strategic Collaboration
Brief: Evelo Biosciences, Abdul Latif Jameel Health Announce Strategic Collaboration
Brief: Evelo Biosciences Reports Quarterly Loss Per Share $0.62
Evelo Biosciences: Falls on discounted share offering
Brief: Evelo Biosciences Announces Pricing Of Public Offering Of Common Stock Of 4,500,000 Shares At $15 Per Share
Brief: Evelo Biosciences Announces Proposed Public Offering Of Common Stock
Brief: Evelo Biosciences Reports New Positive Confirmatory Data From Phase 1B Trial Of EDP1815 In Atopic Dermatitis
Brief: Evelo Biosciences Expands Clinical Programs And Provides 2021 Guidance
NASDAQ RESUMED AT 10:01 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:50 AM
U.S. RESEARCH ROUNDUP-Baker Hughes, Compass Minerals International, Intec pharma
Brief: Evelo Biosciences Prioritizing EDP1908 As Lead Clinical Candidate In Oncology
Evelo Biosciences: Rises on positive data from eczema drug study
Brief: Evelo Biosciences Reports Positive Topline Clinical Data In Phase 1B Trial Of EDP1815 In Atopic Dermatitis
Brief: Evelo Presents New Preclinical Data For Anti-Tumor Effects Of Orally Delivered Microbial Extracellular Vesicles
Brief: Evelo Biosciences Reports Q3 Loss Per Share $0.45
Brief: Evelo Biosciences Completes Enrollment In Phase 1B Clinical Trial Cohort Evaluating EDP1815 In Atopic Dermatitis
Brief: Evelo Biosciences Treats First Patients In Phase 2 Dose-Ranging Trial Of EDP1815
Brief: Evelo Biosciences Treats First Patients In Phase 2 Dose-Ranging Trial Of EDP1815 For Treatment Of Psoriasis